UniSa - IRIS Institutional Research Information System

PERSICO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.492
NA - Nord America 8.131
EU - Europa 2.722
SA - Sud America 598
AF - Africa 68
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.035
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 9.648
US - Stati Uniti d'America 8.019
SG - Singapore 1.015
CN - Cina 911
UA - Ucraina 633
IT - Italia 572
BR - Brasile 517
RU - Federazione Russa 416
DE - Germania 317
VN - Vietnam 315
IE - Irlanda 237
KR - Corea 224
FI - Finlandia 174
TR - Turchia 154
SE - Svezia 112
CA - Canada 84
GB - Regno Unito 65
IN - India 43
JP - Giappone 39
AT - Austria 32
FR - Francia 31
DK - Danimarca 26
NL - Olanda 26
AR - Argentina 25
BD - Bangladesh 24
ZA - Sudafrica 24
ES - Italia 19
EC - Ecuador 18
ID - Indonesia 18
MX - Messico 16
TW - Taiwan 14
IQ - Iraq 12
AU - Australia 11
PL - Polonia 11
VE - Venezuela 11
CO - Colombia 9
PK - Pakistan 9
CZ - Repubblica Ceca 7
EG - Egitto 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
EU - Europa 6
MA - Marocco 6
PY - Paraguay 6
UZ - Uzbekistan 6
BE - Belgio 5
CH - Svizzera 5
PE - Perù 5
SA - Arabia Saudita 5
TN - Tunisia 5
AZ - Azerbaigian 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
PT - Portogallo 4
RO - Romania 4
UG - Uganda 4
BO - Bolivia 3
GR - Grecia 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
ME - Montenegro 3
MW - Malawi 3
MY - Malesia 3
NO - Norvegia 3
TH - Thailandia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BJ - Benin 2
BS - Bahamas 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
OM - Oman 2
PH - Filippine 2
RS - Serbia 2
SN - Senegal 2
TJ - Tagikistan 2
UY - Uruguay 2
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 24.024
Salva come PNG Salva come JPEG
Città #
Hong Kong 9.615
Ann Arbor 1.681
Chandler 838
Jacksonville 819
Princeton 723
Woodbridge 520
Dallas 441
Wilmington 366
Singapore 326
Houston 295
Ashburn 272
Dublin 229
Dong Ket 217
Beijing 209
Andover 164
Nanjing 146
Izmir 142
Pellezzano 128
Boardman 122
Moscow 95
Munich 74
Los Angeles 65
Salerno 64
Hebei 55
Shenyang 54
Naples 53
The Dalles 52
Ottawa 46
Fairfield 45
Changsha 44
São Paulo 44
Nanchang 42
Norwalk 42
Columbus 41
Jiaxing 39
Ho Chi Minh City 35
Düsseldorf 33
Redwood City 33
Nuremberg 29
Tianjin 29
Jinan 28
New York 27
Tokyo 26
Turku 26
Washington 26
Brooklyn 25
Mestre 25
Santa Clara 23
Council Bluffs 20
Falls Church 20
Guangzhou 20
Dearborn 19
London 19
Belo Horizonte 18
Rio de Janeiro 18
Boston 17
Hanoi 17
San Diego 17
Seattle 17
Montreal 16
Helsinki 15
Johannesburg 14
Vienna 14
Brasília 13
Lappeenranta 13
Nürnberg 13
Cambridge 12
Curitiba 12
Pune 12
Rome 12
Seoul 12
Stockholm 12
Zhengzhou 12
Chennai 11
Copenhagen 11
Phoenix 11
San Francisco 11
Amsterdam 10
Chicago 10
Fisciano 10
Jakarta 10
Jinju 10
Milan 10
San Jose 10
San Mango Piemonte 10
Dhaka 9
Ha Kwai Chung 9
Haikou 9
Maletto 9
Charlotte 8
Denver 8
Salvador 8
Warsaw 8
Campinas 7
Caxias do Sul 7
Haiphong 7
Pontecagnano 7
San Giorgio A Cremano 7
Shanghai 7
Ningbo 6
Totale 19.097
Salva come PNG Salva come JPEG
Nome #
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 934
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 728
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study 709
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 682
Non Alcoholic Fatty Liver: Epidemiology and Natural History 594
Impact of telaprevir in HCV patients with cirrhosis and RVR: Real-life data from boceprevir or telaprevir based “triple therapy” experience in southern Italy 572
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 538
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? 501
Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects. 476
Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. 394
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 393
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study 350
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 345
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program 334
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma. 323
Prospective validation of the CLIP score: a new prognostic system for patient with cirrhosis and hepatocellular carcinoma 320
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 290
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 286
442 TNF-alpha and IL-10 genetic polymorphisms influence the natural history and the response to antiviral therapy in HCV related chronic hepatitis 274
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 274
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. 265
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma 258
Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment 256
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort 250
"Non alcoholic fatty liver disease and eNOS dysfunction in humans" 226
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 162
The diagnostic conundrum in non-alcoholic fatty liver disease 157
Non-ulcer dyspepsia and Helicobacter pylori in type 2 diabetic patients: association with autonomic neuropathy. 156
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 155
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 150
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 145
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon. 126
HIGH PREVALENCE OF HEPATITIS C (HCV) INFECTION AND FAVORABLE PROGNOSIS IN PRIMARY HEPATIC LYMPHOMA (PHL) 122
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 121
Coeliac disease and C virus-related chronic hepatitis: a non association 121
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 120
Pharmacotherapy of alcoholic liver disease in clinical practice 119
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 118
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection 118
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 115
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. 114
Alcoholic Liver Disease and Hepatitis C Chronic Infection 112
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 110
[Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach]. 108
[629] THE INFLUENCE OF OBESITY AND DIABETES ON CLINICAL AND THERAPEUTICAL OUTCOME IN HCV RELATED CHRONIC HEPATITIS: AN ITALIAN NATIONWIDE SURVEY STUDY (PROBE GROUP) 103
Age-associated decline of hepatic handling of cholephilic anions in humans is reverted by S-adenosylmethionine (SAMe). 102
A controlled trial on treatment of patients with HCV infection and abnormal liver function tests with or without liver biopsy 102
Ultrasound-guided fine needle aspiration biopsy of portal vein thrombosis in liver cirrhosis: results in 15 patients. 101
Epidemiology and Natural History of Alcoholic Liver Disease 101
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 101
The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report. 100
Antiviral therapy: Why does it fail in HCV-related chronic hepatitis? 100
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 100
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 100
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. 99
[Diabetic neuropathies. IV. Autonomous neuropathy. Peripheral sympathetic innervation and the cardiovascular system]. 98
Risk factors for hospital readmission of elderly patients. 97
Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients 95
Electrophysiological evidence for Na+-coupled bicarbonate transport in cultured rat hepatocytes 94
154 LOW RATE OF ONE-YEAR MORTALITY IN PATIENTS WITH STAGE 4 CIRRHOSIS: THE ITALIAN ASSOCIATION FOR THE STUDY OF LIVER (A.I.S.F.)-EPASCO PROSPECTIVE MULTICENTRE STUDY 94
A 15-Yr Prospective Histological Follow-Up Study in Patients With Persistently Normal Aminotransferase Levels (PNAL) Carrying HCV Infection. 93
A randomised controlled trial on pegylated interferon alfa-2a (40kd)(Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV 92
507 The role of HBV occult infection in patients with non-hodgkin lymphoma: Prevalence and treatment options with nucleotide analogues 92
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. 89
Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition? 89
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 89
Corrigendum to "Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma" [J Hepatol 49 (2008) 557-563] (DOI:10.1016/j.jhep.2008.06.025) 88
Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients. 87
478 Treating chronic hepatitis C in daily practice with PEG-IFN alfa2B and ribavirin. An Italian multicentre study 87
Steatosis as a co-factor in chronic liver diseases 86
A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitis 85
Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of Italy 85
Na+-H+ exchange activity in rat hepatocytes: Role in regulation of intracellular pH 84
Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea 84
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 83
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C 83
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy 83
Adiponectin in hepatology 83
The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: Role of endothelial dysfunction 82
Etiology of newly-diagnosed cases of chronic liver disease in Southern Italy: Results of a prospective multicentric study 82
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 82
93 HCV genotype 2 and 3 can be cured by PEG-IFN-alfa-2B and RBV for 12 wks: A randomized controlled study 81
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 81
Abnormal hepatic uptake of low doses of sulfobromophthalein in Gilbert's syndrome: the role of reduced affinity of the plasma membrane carrier of organic anions. 81
Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humans. 79
Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease 79
Familial clustering of heterogeneous chronic unconjugated hyperbilirubinemia. 78
FN 44 HEPATIC RETINOL BINDING PROTEIN 4 (RBP-4) LEVELS ARE SIGNIFICANTLY RELATED TO THE STEATOHEPATITIS GRADE (COMPROMISSION) BUT NOT WITH HCV INFECTION 78
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study. 78
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 78
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. 77
Clinical management of HCV carriers with normal aminotransferase levels. 76
Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. 76
Chronic liver disease and lymphoproliferative disorders in HCV-positive patients: a working hypothesis. 76
Dissociation between vascular and metabolic effects of nicotinic acid in Gilbert's syndrome. 76
HCV antiviral therapy in injection drug users: difficult to treat or easy to cure? 76
The importance of HCV on burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases 76
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. 75
Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. 75
Alanine aminotransferase measurements and histological disease in hepatitis C. 75
Totale 17.887
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021974 0 0 0 20 149 52 160 13 135 12 180 253
2021/20221.248 6 3 8 6 26 24 34 58 193 169 156 565
2022/20232.009 207 118 63 237 291 430 12 185 301 5 108 52
2023/2024890 82 120 69 32 71 140 32 44 8 34 51 207
2024/20252.756 73 46 56 118 152 290 434 323 486 170 291 317
2025/202611.041 1.663 4.630 4.623 125 0 0 0 0 0 0 0 0
Totale 24.404